“Biosecurity board grapples with how to rein in risky flu studies” (Science)
The National Science Advisory Board for Biosecurity met last week to discuss Gain of Function (GOF) studies. A topic of debate for the past several years, GOF studies involving H5N1 avian influenza and accidents at federal high containment laboratories caused the U.S. government to declare a moratorium in 2014. To find out more about the meeting, including the concerns and recommendations of opponents and researchers, read the article published in Science: http://www.sciencemag.org/news/2016/01/biosecurity-board-grapples-how-rein-risky-flu-studies
Establishing an NIH Office of Infection-Associated Chronic Illness Research can guard against the long-term effects of Covid and lead to novel breakthroughs across many less understood diseases.
The CHIPS and Science Act ushered in unprecedented opportunities for American manufacturing, science, and innovation – and yet, current underfunding leaves the outcomes at risk.
While the U.S. government grapples with the definition of the bioeconomy and what sectors it does and does not contain, another definitional issue needs to be addressed: What does sustainability mean in a bioeconomy?
Federal clearinghouses should incorporate open science practices into their standards and procedures used to identify evidence-based social programs eligible for federal funding.